Walk-in Drive at Intas Pharmaceuticals for QC Roles
The Intas Pharma walk-in offers aspiring professionals an opportunity to attend a walk-in drive in Sikkim for Intas Pharmaceuticals Ltd.’s Matoda, Ahmedabad facility. This event will take place on Sunday, 1 November 2026, from 09:30 AM to 05:00 PM, offering various positions across engineering, manufacturing, quality control, and microbiology.
- Post: Executive / Senior Officer / Officer – Quality Control
- Qualification: M.Sc. (Organic Chemistry / Analytical Chemistry), B.Pharm / M.Pharm
- Experience: 2 to 7 years
About Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. is a leading global pharmaceutical company based in India, specializing in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations. With a strong commitment to quality and innovation, Intas operates in various therapeutic segments, providing high-quality medicines to patients worldwide. The company is known for its robust manufacturing capabilities and adherence to international regulatory standards.
Job Details
- Walk-in Date: Sunday, 1 November 2026
- Time: 09:30 AM to 05:00 PM
- Venue: Palm Grove Suites Inn, Majitar, beside Kaiser Kunti Fuels, Rangpo, Sikkim 737136
Eligibility Criteria
For this Intas walk-in interview, experience in a regulatory-approved pharmaceutical facility with knowledge of cGMP norms and laboratory safety is expected. Candidates who have appeared for an interview at Intas in the last six months should not apply. Intas does not charge any fee for job application, processing, training, or testing.
How to Attend the Intas Pharmaceuticals Walk-in Drive?
Attend the walk-in interview on the date, time, and venue mentioned above with your updated CV and required documents.
This Intas Pharma walk-in presents a significant opportunity for qualified candidates to advance their careers in the pharmaceutical industry. Interested individuals are encouraged to attend the interview on the specified date and time to explore these exciting positions.
CLICK HERE FOR THE ORIGINAL NOTIFICATION